Difference between revisions of "Part:BBa K5324011:Design"

Latest revision as of 01:48, 30 September 2024

Aprotinin Secretion Device

Assembly Compatibility:

10
COMPATIBLE WITH RFC[10]
12
INCOMPATIBLE WITH RFC[12]
Illegal NheI site found at 7
Illegal NheI site found at 30
21
COMPATIBLE WITH RFC[21]
23
COMPATIBLE WITH RFC[23]
25
COMPATIBLE WITH RFC[25]
1000
COMPATIBLE WITH RFC[1000]

Design Notes

Aprotinin sequence was codon optimized for expression in E.coli.

Source

Aprotinin originated from Bos taurus.

References

1 - Vedvick, T.S. (1993) ‘DNA for expression of aprotinin in methylotrophic yeast cells’.
2 - Moitra, V. et al. (2009) ‘What is the best means of preventing perioperative renal injury?’, Evidence-Based Practice of Anesthesiology, pp. 226–239. doi:10.1016/b978-1-4160-5996-7.00034-1.
3 - Thomas, S., Holland, I.B. and Schmitt, L. (2014) ‘The type 1 secretion pathway — the hemolysin system and beyond’, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1843(8), pp. 1629–1641. doi:10.1016/j.bbamcr.2013.09.017.

@@ Line 16: / Line 16: @@
 ===References===
-- Vedvick, T.S. (1993) ‘DNA for expression of aprotinin in methylotrophic yeast cells’.
+- Vedvick, T.S. (1993) ‘DNA for expression of aprotinin in methylotrophic yeast cells’. <br>
-- Moitra, V. et al. (2009) ‘What is the best means of preventing perioperative renal injury?’, Evidence-Based Practice of Anesthesiology, pp. 226–239. doi:10.1016/b978-1-4160-5996-7.00034-1.
+- Moitra, V. et al. (2009) ‘What is the best means of preventing perioperative renal injury?’, Evidence-Based Practice of Anesthesiology, pp. 226–239. doi:10.1016/b978-1-4160-5996-7.00034-1. <br>
+- Thomas, S., Holland, I.B. and Schmitt, L. (2014) ‘The type 1 secretion pathway — the hemolysin system and beyond’, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1843(8), pp. 1629–1641. doi:10.1016/j.bbamcr.2013.09.017. <br>